Asia- Pacific region is a hotspot for medical devices. Advancing technologies, aging populations, growing economies and increasing health care spending by individuals and governments, offer vast growth for multinational and local medical device companies.

The region is diverse, and each country presents a complex and challenging regulatory landscape. Gaining market access to Asia Pacific requires a deep understanding of the regulations, culture and payer expectations. Development and commercialization strategies must be aligned with regulatory and market demands, coupled with collaborative relationships with payers, providers and vendors.


IQVIA offers an integrated solution for medical device and diagnostics companies to: 


Navigate complex regulatory environment 

Optimize medical device clinical development  

Accelerate market approvals 

Develop strategies for better commercial performance 




Regulatory Services

Evaluate current regulations, analyze impact of regulatory changes and assess registration pathways to help navigate the complex regulatory environment.

Clinical Trials

Preferred provider by the world’s largest medical device companies

Accelerate timelines and chart a precise path via our optimized clinical trial management processes

Consulting Services

Harness our consulting capabilities to fast-forward your commercial performance via global insights, rigorous analyses, strategic recommendations and in-market execution support

Market Analytics

Gain critical and actionable data-based insights into the promise of your device or diagnostic product using our unique information and analytics solution for Asia Pacific 

Therapeutic Expertise

Cardiovascular, Orthopedics, Oncology, Dermatology, and Diabetes Care and Endocrinology  


In Vitro Diagnostics (IVD) and Companion Diagnostics (CDx)  




Medtech Development the Asia Way
Asia is on the rise in medical techonology development and sales. This paper examines the opportunity for medtech in Asia, common pitfalls and how to avoid them, and the use of strategic outsourcing to realize greater value and mitigate risks
The increasing importance of market access for medtech in APAC
Regardless of category types, the de facto go-to-market entry strategy for a medtech company large or small, had mostly been to hire local distributors to take on the standard service output demands of availing products and services to market while they focus on larger (and more attractive) markets and R&D activities.